CAR-Immunotherapy TRIALS

CAR-Immunotherapy package has 22 parameters for all trials registered internationally from 2001 through 30 June 2020, including their current status. Cumulatively, 1036 CAR-Immunotherapy trials have been registered worldwide (see histogram below).

  • Trial Data
    • Registration Year
    • Trial ID with link to trial on-line
    • Country
    • Phase
    • Status (updated as of 17 Sept. 2020)
  • Patient Data
    • Indication
    • Patient Age Groups
    • Target Enrollment
  • Cell Data
    • CAR Target
    • Cell Type
    • Cell Source
    • Donor Type
    • CAR Construct (costimulatory domain, vector, etc)
    • Cell Dose(s)
    • Mode of Administration (route and # doses)
    • Conditioning
    • Drug Support/Combos
  • Sponsor Data
    • Academia or Industry Funding
    • Sponsor Name
    • Study Acronym
  • Additional Information
    • Product Name
    • Notes - includes secondary trial IDs and reasons for termination

Below is a histogram of CAR-Immunotherapy trial numbers versus time, color-coded by trial phase. This illustrates the explosion of CAR-Immunotherapy trials since 2014 and the appearance of follow-up studies since 2015. During 2019, 33% of new CAR-Immunotherapy trials were not registered in ClinicalTrials.gov.

CAR-Immunotherapy trials by phase versus year

Public samples:
AttachmentSize
SAMPLE CAR-immunotherapy Trials12.19 KB